Glenn Greenberg
Brave Warrior Advisors
Glenn Greenberg UnitedHealth Group Incorporated stake
total: 106
Brave Warrior Advisors UNH trades
- Total transactions:
- 19
- New positions:
- 2
- Sold out:
- 1
- Added:
- 4
- Reduced:
- 12
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Glenn Greenberg holds 499 UnitedHealth Group Incorporated (UNH) shares with a market value of roughly $207.40K accounting for 0.00% of the overall portfolio. To date, the estimated cost basis is nearly $415.63 for "buy" trades. Brave Warrior Advisors first purchased UNH in 2019 Q4, initially acquiring 159,089 shares. Glenn Greenberg later completely sold out the position and invested in UnitedHealth Group Incorporated again in 2026 Q2. Since the initial investment in UnitedHealth Group Incorporated (UNH), Brave Warrior Advisors has made 18 more transactions.
When did Glenn Greenberg buy UnitedHealth Group Incorporated (UNH)?
Glenn Greenberg first invested in UnitedHealth Group Incorporated (UNH) in 2019 Q4 at the reported quarter-end price of $293.98 per share.
What's the cost basis of Brave Warrior Advisors's UNH stake?
The estimated cost basis for UnitedHealth Group Incorporated (UNH) stake is around $415.63 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $415.63
Glenn Greenberg's historical trades in UnitedHealth Group Incorporated
19 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
499
|
$415.63
|
$207,399
|
new
|
+0%
|
|
2025 Q3
|
0.00%
|
0
|
$311.97
|
|
-100% (-1,499)
|
-0.01%
|
|
2025 Q2
|
0.01%
|
1,499
|
$311.97
|
$467,643
|
+200.40% (+1,000)
|
+0.01%
|
|
2024 Q3
|
0.01%
|
499
|
$584.68
|
$291,755
|
-18.20% (-111)
|
-0%
|
|
2023 Q4
|
0.01%
|
610
|
$526.47
|
$321,147
|
-14.08% (-100)
|
-0%
|
|
2023 Q3
|
0.01%
|
710
|
$504.19
|
$357,975
|
-35.80% (-396)
|
-0.01%
|
|
2023 Q1
|
0.02%
|
1,106
|
$472.59
|
$522,685
|
-8.29% (-100)
|
-0%
|
|
2022 Q4
|
0.02%
|
1,206
|
$530.18
|
$639,397
|
-51.09% (-1,260)
|
-0.02%
|
|
2022 Q2
|
0.04%
|
2,466
|
$513.79
|
$1,267,000
|
-30.65% (-1,090)
|
-0.02%
|
|
2022 Q1
|
0.05%
|
3,556
|
$509.84
|
$1,813,000
|
-98.40% (-218,105)
|
-3.54%
|
|
2021 Q4
|
3.55%
|
$502.14
|
-1.97% (-4,460)
|
|||
|
2021 Q3
|
3.09%
|
$390.74
|
-6.57% (-15,898)
|
|||
|
2021 Q2
|
3.33%
|
$400.44
|
-1.79% (-4,411)
|
|||
|
2021 Q1
|
2.99%
|
$372.07
|
+51.08% (+83,316)
|
|||
|
2020 Q4
|
2.10%
|
$350.68
|
+2.01% (+3,213)
|
|||
|
2020 Q3
|
2.23%
|
$311.77
|
-3.38% (-5,590)
|
|||
|
2020 Q2
|
2.43%
|
$294.95
|
-37.10% (-97,609)
|
|||
|
2020 Q1
|
3.78%
|
$249.38
|
+65.38% (+104,011)
|
|||
|
2019 Q4
|
2.47%
|
$293.98
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.